Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 96,300 shares, an increase of 20.7% from the May 31st total of 79,800 shares. Currently, 1.6% of the company’s shares are short sold. Based on an average daily volume of 1,130,000 shares, the short-interest ratio is presently 0.1 days.
Qualigen Therapeutics Stock Up 3.0 %
Shares of QLGN opened at $0.17 on Tuesday. The stock’s 50-day moving average price is $0.25 and its two-hundred day moving average price is $0.39. Qualigen Therapeutics has a 12 month low of $0.14 and a 12 month high of $1.26.
About Qualigen Therapeutics
Further Reading
- Five stocks we like better than Qualigen Therapeutics
- How to Invest in the Best Canadian StocksĀ
- Steel Dynamics Stock is Up 9.6% While Its Peers Are Rusting
- Options Trading – Understanding Strike Price
- The Top 4 Magnificent 7 Stocks to Buy in the Year’s Second Half
- Trading Stocks: RSI and Why it’s Useful
- Snowflake Stock Rebounds, Flies Higher on AI Spending
Receive News & Ratings for Qualigen Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qualigen Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.